| 1 |
34472497 | Comparing the effect of xenon and sevoflurane anesthesia on postoperative neural injury biomarkers: a randomized controlled trial. | 2022 Jan-Mar |
1 |
| 2 |
34545670 | Enhanced identification of Tau acetylation and phosphorylation with an engineered aerolysin nanopore. | 2022 Mar |
1 |
| 3 |
34928318 | Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. | 2022 Feb 1 |
1 |
| 4 |
35015198 | Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer's disease progression. | 2022 Mar |
1 |
| 5 |
35078917 | Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy. | 2022 Jun |
1 |
| 6 |
35099506 | Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. | 2022 Mar 1 |
2 |
| 7 |
35250029 | Genome-wide association study identifies APOE locus influencing plasma p-tau181 levels. | 2022 Mar 7 |
1 |
| 8 |
35305339 | Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. | 2022 Apr |
1 |
| 9 |
35307816 | Dopamine transporter SPECT imaging in corticobasal syndrome: A peak into the underlying pathology? | 2022 Jun |
1 |
| 10 |
35370599 | Association Between Plasma Apolipoprotein M With Alzheimer's Disease: A Cross-Sectional Pilot Study From China. | 2022 |
1 |
| 11 |
35504110 | Altered amyloid-β and tau proteins in neural-derived plasma exosomes in obstructive sleep apnea. | 2022 Jun |
1 |
| 12 |
35554506 | Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy. | 2022 May 13 |
1 |
| 13 |
33165506 | Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease. | 2021 Feb 1 |
1 |
| 14 |
33249783 | Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease. | 2021 Jan |
1 |
| 15 |
33380426 | Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation. | 2021 Jan-Jun |
1 |
| 16 |
33427873 | Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease. | 2021 Apr 1 |
1 |
| 17 |
33469985 | Protein kinase G phosphorylates the Alzheimer's disease-associated tau protein at distinct Ser/Thr sites. | 2021 Jan |
1 |
| 18 |
33470669 | Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease. | 2021 Apr 1 |
3 |
| 19 |
33585983 | Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology. | 2021 May |
1 |
| 20 |
33607852 | Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit. | 2021 Feb 19 |
1 |
| 21 |
33638255 | Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis. | 2021 Jun |
1 |
| 22 |
33814431 | Tau Protein Phosphorylated at Threonine-231 is Expressed Abundantly in the Cerebellum in Prion Encephalopathies. | 2021 |
2 |
| 23 |
33842885 | Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers. | 2021 |
3 |
| 24 |
33947453 | Characterization of Alzheimer's tau biomarker discordance using plasma, CSF, and PET. | 2021 May 4 |
1 |
| 25 |
34119372 | A genome-wide association study of plasma phosphorylated tau181. | 2021 Oct |
1 |
| 26 |
34122046 | Better Identification of Cognitive Decline With Interleukin-2 Than With Amyloid and Tau Protein Biomarkers in Amnestic Mild Cognitive Impairment. | 2021 |
1 |
| 27 |
34225797 | Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer's disease. | 2021 Jul 5 |
1 |
| 28 |
34262030 | Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome. | 2021 Jul 14 |
1 |
| 29 |
34342183 | MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology. | 2021 Sep |
1 |
| 30 |
34418401 | Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study. | 2021 Sep |
3 |
| 31 |
34493616 | Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays. | 2021 Oct 26 |
2 |
| 32 |
34692979 | Higher cerebrospinal fluid tau is associated with history of traumatic brain injury and reduced processing speed in Vietnam-era veterans: A Department of Defense Alzheimer's Disease Neuroimaging Initiative (DOD-ADNI) study. | 2021 |
1 |
| 33 |
32333900 | Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. | 2020 May |
1 |
| 34 |
33068398 | Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease. | 2020 Dec 5 |
1 |
| 35 |
30590647 | Tau/MAPT disease-associated variant A152T alters tau function and toxicity via impaired retrograde axonal transport. | 2019 May 1 |
2 |
| 36 |
30767082 | Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease. | 2019 Mar |
1 |
| 37 |
30985105 | O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease. | 2019 May 15 |
1 |
| 38 |
31267651 | Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease. | 2019 Oct |
2 |
| 39 |
31399291 | A Possible Neurodegeneration Mechanism Triggered by Diabetes. | 2019 Oct |
1 |
| 40 |
31504677 | Tau Phosphorylation and Aggregation in the Developing Human Brain. | 2019 Oct 1 |
2 |
| 41 |
32096026 | Nuclear Magnetic Resonance Spectroscopy Insights into Tau Structure in Solution: Impact of Post-translational Modifications. | 2019 |
1 |
| 42 |
29376870 | Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease. | 2018 |
2 |
| 43 |
29462698 | Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells. | 2018 May 10 |
1 |
| 44 |
30021611 | Alzheimer disease pathology and the cerebrospinal fluid proteome. | 2018 Jul 18 |
1 |
| 45 |
30261006 | Designing antibodies against LRRK2-targeted tau epitopes. | 2018 |
6 |
| 46 |
27636850 | Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates. | 2017 |
1 |
| 47 |
27914953 | Both secreted and the cellular levels of BDNF attenuated due to tau hyperphosphorylation in primary cultures of cortical neurons. | 2017 Mar |
1 |
| 48 |
27989667 | Ser422 phosphorylation blocks human Tau cleavage by caspase-3: Biochemical implications to Alzheimer's Disease. | 2017 Feb 1 |
1 |
| 49 |
28044435 | Expanding the cerebrospinal fluid endopeptidome. | 2017 Mar |
2 |
| 50 |
28332604 | Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters. | 2017 Mar 23 |
1 |